TABLE 1.
Patient characteristics and serum IL‐35 levels (n = 86,mean ± SD)
| Variable | n (%) | IL‐35 (pg/ml) | p‐value |
|---|---|---|---|
| Sex | 0.1595 | ||
| Male | 62 | 78.18 ± 26.06 | |
| Female | 24 | 69.79 ± 20.13 | |
| Age | 0.4085 | ||
| <65 | 36 | 73.22 ± 30.72 | |
| ≥65 | 50 | 77.72 ± 19.43 | |
| Treatment | ≥0.0755 | ||
| Chemotherapy | 35 | 68.48 ± 24.03 | |
| Targeted therapy | 24 | 77.08 ± 18.89 | |
| Supportive care | 27 | 80.66 ± 27.88 | |
| BMI(kg/m 2 ) | ≥0.1509 | ||
| Underweight | 7 | 63.86 ± 17.97 | |
| Normal | 44 | 75.98 ± 25.9 | |
| Overweight/obesity | 35 | 78.06 ± 24.25 | |
| Cachexia | <0.001*** | ||
| No | 32 | 63.09 ± 19.13 | |
| Yes | 54 | 84.07 ± 27.01 |
Abbreviations: BMI, body mass index.
***
p < 0.001.